Literature DB >> 1359115

Comparison of the role of local anesthetic properties with dopamine uptake blockade in the inhibition of striatal and nucleus accumbens [3H]acetylcholine release by cocaine.

A N Gifford1, K M Johnson.   

Abstract

The effects of cocaine on the electrically evoked release of tritium from brain slices previously loaded with [3H]choline were examined and used as an index of acetylcholine (ACh) release. In the striatum, cocaine dose-dependently inhibited ACh release, with an IC50 of 2.9 microM. At 10 microM cocaine, D2 receptor blockade by sulpiride resulted in only about a 45% reversal of the inhibition of ACh release, whereas inhibition due to either nomifensine or quinpirole was reversed by about 80%. 5-Hydroxytryptamine antagonists had no effect on the cocaine-induced inhibition of striatal ACh release, thus suggesting no involvement of this amine in cocaine's action. Antagonists against gamma-aminobutyric acidA, muscarinic, opioid and adenosine receptors were similarly ineffective at reversing cocaine's effect on ACh release. Comparison with the effect of procaine on striatal ACh release suggested that the inhibition of ACh release in the presence of sulpiride was due to the local anesthetic properties of cocaine. In the nucleus accumbens cocaine was about 5-fold less potent at inhibiting ACh release than in the striatum and sulpiride was much less effective at reversing the inhibitory effect of cocaine, suggesting that the local anesthetic effects of cocaine play a greater role in regulating ACh release in this area relative to dopamine uptake blockade. These data suggest that the local anesthetic effect of cocaine is prominent at concentrations found in the central nervous system after pharmacologically relevant systemic doses and depending on the degree of monoaminergic control of a particular brain area, may be even more important than the effects of cocaine arising from inhibition of reuptake.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359115

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Presynaptic dopaminergic function is largely unaltered in mesolimbic and mesostriatal terminals of adult rats that were prenatally exposed to cocaine.

Authors:  Paul E M Phillips; Josephine M Johns; Deborah A Lubin; Evgeny A Budygin; Raul R Gainetdinov; Jeffery A Lieberman; R Mark Wightman
Journal:  Brain Res       Date:  2003-01-24       Impact factor: 3.252

2.  Brain temperature change and movement activation induced by intravenous cocaine delivered at various injection speeds in rats.

Authors:  P Leon Brown; Eugene A Kiyatkin
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

3.  The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.

Authors:  Eugene A Kiyatkin; P Leon Brown
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

4.  Cocaine disinhibits dopamine neurons in the ventral tegmental area via use-dependent blockade of GABA neuron voltage-sensitive sodium channels.

Authors:  Scott C Steffensen; Seth R Taylor; Malia L Horton; Elise N Barber; Laura T Lyle; Sarah H Stobbs; David W Allison
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

5.  Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output.

Authors:  A Zocchi; A Pert
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

6.  I.v. cocaine induces rapid, transient excitation of striatal neurons via its action on peripheral neural elements: single-cell, iontophoretic study in awake and anesthetized rats.

Authors:  E A Kiyatkin; P L Brown
Journal:  Neuroscience       Date:  2007-07-17       Impact factor: 3.590

7.  Involvement of reactive oxygen species in cocaine-taking behaviors in rats.

Authors:  Eun Young Jang; Yeon-Hee Ryu; Bong Hyo Lee; Su-Chan Chang; Mi Jin Yeo; Sang Hyun Kim; Ryan J Folsom; Nathan D Schilaty; Kwang Joong Kim; Chae Ha Yang; Scott C Steffensen; Hee Young Kim
Journal:  Addict Biol       Date:  2014-06-26       Impact factor: 4.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.